Eye drops could save sight in rare corneal melting disease
NCT ID NCT02987686
First seen May 07, 2026 · Last updated May 15, 2026 · Updated 2 times
Summary
This early study tested whether infliximab, a medicine usually given through a vein, can be safely used as eye drops to treat sterile corneal melt. This rare condition causes the clear front part of the eye to thin and can lead to blindness. Seven adults with the condition took part to see if the drops were safe and if they could help heal the eye.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STERILE CORNEAL MELT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, H2X3E4, Canada
Conditions
Explore the condition pages connected to this study.